New insights in intestinal ischemia-reperfusion injury: Implications for intestinal transplantation

Current Opinion in Organ Transplantation

Volumn 18, Issue 3, 2013, Pages 298-303

  Lenaerts, Kaatje ^a   Ceulemans, Laurens J ^b   Hundscheid, Inca H R ^a   Grootjans, Joep ^a,c   Dejong, Cornelis H C ^a   Damink, Steven W M Olde ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Slotervaartziekenhuis ^*  (Netherlands)

Author keywords

Innate immune activation; Intestine; Ischemia reperfusion; Rejection

Indexed keywords

COMPLEMENT; IMMUNOSUPPRESSIVE AGENT; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTESTINE GRAFT; INTESTINE ISCHEMIA; INTESTINE TRANSPLANTATION; MAST CELL; NEUTROPHIL; PANETH CELL; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE; THROMBOCYTE; ENTEROPATHY; IMMUNOLOGY; INTESTINE; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TRANSPLANTATION;

GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; INTESTINAL DISEASES; INTESTINES; POSTOPERATIVE COMPLICATIONS; REPERFUSION INJURY;

MLCS; MLOWN;

EID: 84879909929     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835ef1eb     Document Type: Review

References (62)

1. Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361:998-1008.
2. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250:567-581.
3. Selvaggi G, Tzakis AG. Intestinal and multivisceral transplantation: future perspectives. Front Biosci 2007; 12:4742-4754.
4. Kawai M, Kitade H, Koshiba T, et al. Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection. Transplantation 2009; 87:1464-1467.
5. Chong A, Alegre M-L. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol 2012; 12:459-471.
6. Lutz J, Thurmel K, Heemann U. Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) 2010; 7:27.
7. Benichou G, Tonsho M, Tocco G, et al. Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol 2012; 3:73.
8. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol 2010; 11:656-665.
9. Grootjans J, Lenaerts K, Derikx JP, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol 2010; 176:2283-2291.
10. Beebe DS, Kim S, Belani KG, et al. Endotoxemia during small bowel transplantation in pigs. Transplant Proc 1995; 27:593-594.
11. Li X, Zhong R, Quan D, et al. Endotoxin in the peripheral blood during acute intestinal allograft rejection. Transpl Int 1994; 7:223-226.
12. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3:169-176.
13. Kojima M, Tanabe M, Shinoda M, et al. Role of high mobility group box chromosomal protein 1 in ischemia-reperfusion injury in the rat small intestine. J Surg Res 2012; 178:466-471.
14. Grootjans J, Hodin CM, de Haan JJ, et al. Level of activation of the unfolded protein response correlates with Paneth cell apoptosis in human small intestine exposed to ischemia/reperfusion. Gastroenterology 2011; 140:529.e3-539.e3.
15. Vaishnava S, Behrendt CL, Ismail AS, et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 2008; 105:20858-20863.
16. Kaser A, Blumberg RS. Paneth cells and inflammation dance together in Crohn's disease. Cell Res 2008; 18:1160-1162.
17. Sato T, van Es JH, Snippert HJ, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011; 469:415-418.
18. Ben Mosbah I, Alfany-Fernandez I, Martel C, et al. Endoplasmic reticulum stress inhibition protects steatotic and nonsteatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis 2010; 1:e52.
19. Pallet N, Fougeray S, Beaune P, et al. Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 2009; 88:605-613.
20. Lee H, Kim M, Kim J, et al. Critical role of interleukin-17A in murine intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2013; 304:G12-G25.
21. Park SW, Kim M, Brown KM, et al. Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology 2011; 53:1662-1675.
22. Park SW, Kim M, Kim JY, et al. Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J Immunol 2012; 189:5421-5433.
23. Blikslager AT, Moeser AJ, Gookin JL, et al. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 2007; 87:545-564.
24. Lu Y-Z, Wu C-C, Huang Y-C, et al. Neutrophil priming by hypoxic preconditioning protects against epithelial barrier damage and enteric bacterial translocation in intestinal ischemia/reperfusion. Lab Invest 2012; 92:783-796.
25. Miller HR, Pemberton AD. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002; 105:375-390.
26. Gan X, Liu D, Huang P, et al. Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating PAR-2 in rats. Inflammation 2012; 35:1144-1153.
27. Kalia N, Brown N, Wood R, Pockley A. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol 2005; 20:1032-1038.
28. Kirk A, Morrell C, Baldwin W. Platelets influence vascularized organ transplants from start to finish. Am J Transplant 2009; 9:14-22.
29. Lapchak P, Kannan L, Ioannou A, et al. Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2012; 302:G888-G897.
30. Lapchak P, Ioannou A, Rani P, et al. The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury. PLoS One 2012; 7.
31. Lapchak P, Ioannou A, Kannan L, et al. Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury. PLoS One 2012; 7.
32. Hagiwara S, Iwasaka H, Hasegawa A, et al. Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine. Surg Today 2010; 40:137-145.
33. Moses T, Wagner L, Fleming SD. TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol 2009; 86:971-980.
34. Watanabe T, Kobata A, Tanigawa T, et al. Activation of the MyD88 signaling pathway inhibits ischemia-reperfusion injury in the small intestine. Am J Physiol Gastrointest Liver Physiol 2012; 303:G324-G334.
35. Chassin C, Hempel C, Stockinger S, et al. MicroRNA-146a-mediated down-regulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol Med 2012; 4:1308-1319.
36. Reino D, Palange D, Feketeova E, et al. Activation of Toll-like receptor 4 is necessary for trauma hemorrhagic shock-induced gut injury and polymorpho-nuclear neutrophil priming. Shock 2012; 38:107-114.
37. Hart ML, Ceonzo KA, Shaffer LA, et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005; 174:6373-6380.
38. Schwaeble W, Lynch N, Clark J, et al. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2011; 108:7523-7528.
39. Sacks S, Zhou W. The role of complement in the early immune response to transplantation. Nat Rev Immunol 2012; 12:431-442.
40. Pope M, Bukovnik U, Tomich J, Fleming S. Small b2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J Immunol 2012; 189:5047-5056.
41. Zhang M, Austen WG Jr, Chiu I, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2004; 101:3886-3891.
42. Round J, Mazmanian S. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323.
43. Li Q, Zhang Q, Wang C, et al. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoS One 2011; 6:e20460.
44. Wang F, Li Q, Wang C, et al. Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury. PLoS One 2012; 7.
45. Wang H, Zhang W, Zuo L, et al. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr DOI 10.1017/s0007114512004308.
46. Grootjans J, Hundscheid IH, Lenaerts K, et al. Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon. Gut 2013; 62:250-258.
47. Kumar A, Li X, Leblanc J, et al. Proteomic analysis reveals innate immune activity in intestinal transplant dysfunction. Transplantation 2011; 92:112-119.
48. Shen H, Song Y, Colangelo C, et al. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest 2012; 122:383-387.
49. Zager R, Vijayan A, Johnson A. Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury 'stress response'. Am J Physiol Renal Physiol 2012; 303:F139-F148.
50. Ezzelarab M, Thomson A. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 2011; 23:252-263.
51. De Vries V, Pino-Lagos K, Nowak E, et al. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 2011; 35:550-561.
52. Yang X, Meng S, Jiang H, et al. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. J Surg Res 2011; 171:826-832.
53. Watson M, Ke B, Shen X-D, et al. Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice. Surgery 2012; 152:843-850.
54. Pergel A, Kanter M, Yucel A, et al. Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury. Toxicol Ind Health 2012; 28:923-932.
55. Ban K, Kozar R. Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice. PLoS One 2012; 7.
56. Wen S-H, Li Y, Li C, et al. Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation. Shock 2012; 38:411-419.
57. Lenaerts K, Renes J, Bouwman FG, et al. Arginine deficiency in preconfluent intestinal Caco-2 cells modulates expression of proteins involved in proliferation, apoptosis, and heat shock response. Proteomics 2007; 7:565-577.
58. Lenaerts K, Mariman E, Bouwman F, Renes J. Glutamine regulates the expression of proteins with a potential health-promoting effect in human intestinal Caco-2 cells. Proteomics 2006; 6:2454-2464.
59. Peng Z, Ban K, Sen A, et al. Syndecan-1 plays a novel role in enteral glutamine's gut protective effects of the post ischemic gut: Role of syndecan-1 in gut protection by glutamine. Shock DOI 10.1097/SHK.0b013e31825a188a.
60. Lee CH, Hsiao CC, Hung CY, et al. Long-term enteral arginine supplementation in rats with intestinal ischemia and reperfusion. J Surg Res 2012; 175:67-75.
61. Yi L, Lingshan G, Cui Y, et al. A preliminary study on protective effect of L-citrulline against ischemia-reperfusion induced gastric mucosal lesions in rat. Indian J Pharmacol 2012; 44:31-35.
62. Wijnands KA, Vink H, Briede JJ, et al. Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One 2012; 7:e37439.